Bill Sponsor
House Bill 3271
115th Congress(2017-2018)
Protecting Access to Diabetes Supplies Act of 2017
Introduced
Introduced
Introduced in House on Jul 17, 2017
Overview
Text
Introduced
Jul 17, 2017
Latest Action
Dec 6, 2017
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3271
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
House Votes (0)
Senate Votes (0)
No House votes have been held for this bill.
Summary

Protecting Access to Diabetes Supplies Act of 2017

This bill amends title XVIII (Medicare) of the Social Security Act to modify provisions relating to Medicare's competitive acquisition program (through which rates are set through a competitive bidding program rather than by an established fee schedule) with respect to diabetic testing strips. Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to:

  • use specified data to determine whether a bid satisfies certain requirements related to volume of coverage with respect to such products,
  • reject a bid if the bidder does not demonstrate its ability to furnish such products in a manner consistent with its bid, and
  • establish a process to monitor the extent to which an entity continues to cover the product types included in its bid.

The CMS may terminate a contract if it determines that an entity, for reasons other than product discontinuation or market-wide shortage, fails to maintain ready access to such products included its bid.

In addition, the bill specifies that an entity furnishing such products to beneficiaries under the program: (1) must furnish to each beneficiary a brand of strips that is compatible with the beneficiary's home blood glucose monitor, (2) may not attempt to influence or incentivize a beneficiary to switch the brand of either type of product, and (3) must contact and receive a request from a beneficiary no more than 14 days prior to dispensing a refill to the beneficiary.

Text (2)
December 6, 2017
July 17, 2017
Actions (11)
12/06/2017
Placed on the Union Calendar, Calendar No. 329.
12/06/2017
Committee on Ways and Means discharged.
12/06/2017
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-447, Part I.
10/04/2017
Ordered to be Reported by Voice Vote.
10/04/2017
Committee Consideration and Mark-up Session Held.
09/13/2017
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
09/13/2017
Subcommittee Consideration and Mark-up Session Held.
07/31/2017
Referred to the Subcommittee on Health.
07/21/2017
Referred to the Subcommittee on Health.
07/17/2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/17/2017
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:37:25 PM